News

Germany's Merck says in late-stage discussions to buy SpringWorks for $3.5 billion
Germany's Merck KGaA said on Thursday it is in late-stage talks to acquire U.S.-based SpringWorks Therapeutics for about $3.5 ...
GlobalData on MSN17h
Merck KGaA nears $3.5bn deal for SpringWorks
Merck KGaA has confirmed that it is in late-stage discussions with SpringWorks, valuing the deal at a price of around $47 per ...
Nordot on MSN22h
German pharma giant Merck close to takeover of US cancer specialist
Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...
akm23h
German pharmaceutical company Merck intends to acquire American SpringWorks for $3.4 billion
The German pharmaceutical company Merck KGaA is negotiating the acquisition of the American manufacturer of drugs for the treatment of cancer and rare diseases SpringWorks Therapeutics Inc. This is ...